Dan Huang

Ms. Dan Huang

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2021 in Epidemiology and Health
Verified
Journal Article
Open access
PDF file
DHDan Huang
Dan Huang
HJHyundeok Joo
Hyundeok Joo
NSNan Song
Nan Song
SCSooyoung Cho
Sooyoung Cho
WKWoosung Kim
Woosung Kim
ASAesun Shin
Aesun Shin
OBJECTIVES: Biliary tract cancers (BTCs) are rare but highly fatal. Although the etiology of BTC is poorly understood, gallstones are proposed to be a major risk factor. We conducted a systematic review and meta-analysis to examine the associations between gallstone characteristics and BTC risk.METHODS: We searched the MEDLINE, Embase, and Cochrane Central databases and systematically reviewed cohort and case-control studies published before April 9, 2018. All the included studies reported appropriate risk estimates and confidence intervals (CIs) for associations between the presence, size, number, or duration of gallstones and the risk of BTC, including gallbladder cancer (GBC), extrahepatic bile duct cancer (EBDC), and ampulla of Vater cancer (AOVC). Summary odds ratios (ORs) and their 95% CIs were calculated using a random-effects model in the meta-analysis. Subgroup analyses were conducted to inspect sources of potential heterogeneity, and the Egger test was performed to assess publication bias.RESULTS: Seven cohort studies and 23 case-control studies in Asian, European, and American populations were included. The presence of gallstones was associated with an increased risk of BTC (OR, 4.38; 95% CI, 3.23 to 5.93; I2=91.2%), GBC (OR, 7.26; 95% CI, 4.33 to 12.18), EBDC (OR, 3.17; 95% CI, 2.24 to 4.50), and AOVC (OR, 3.28; 95% CI, 1.33 to 8.11). Gallstone size (>1 vs. <1 cm; OR, 1.88; 95% CI, 1.10 to 3.22) was significantly associated with the risk of GBC.CONCLUSIONS: Gallstone characteristics, such as presence, size, and number, are associated with an increased risk of BTC. However, significantly high heterogeneity in the meta-analyses is a limitation of this study.

30 September 2020 in Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
DHDan Huang
Dan Huang
JLJoonki Lee
Joonki Lee
NSNan Song
Nan Song
SCSooyoung Cho
Sooyoung Cho
SCSunho Choe
Sunho Choe
ASAesun Shin
Aesun Shin
Dan Huang, Joonki Lee, Nan Song, Sooyoung Cho, Sunho Choe, Aesun Shin. J Cancer Prev 2020;25:164-72. https://doi.org/10.15430/JCP.2020.25.3.164

28 April 2022 in Cancer Biology & Medicine
Verified
Journal Article
Open access
PDF file
HLHwi-Won Lee
Hwi-Won Lee
DHDan Huang
Dan Huang
WSWoo-Kyoung Shin
Woo-Kyoung Shin
KTKatherine de la Torre
Katherine de la Torre
MSMinkyo Song
Minkyo Song
Daehee KangDaehee Kang
Daehee Kang
Objective: Epidemiological studies indicate that alcohol increases gastric cancer (GC) risk, yet most studies have focused on heavy alcohol intake, leaving other factors understudied. A comprehensive investigation of the effects of the frequency and amount of alcohol intake may help elucidate the GC risk associated with drinking behavior. Methods: The Health Examinees-Gem (HEXA-G) study, a community-based large-scale prospective cohort study, enrolled Korean adults 40–69 years of age between the years 2004 and 2013. Incident GC cases were identified through linkage to Korea Central Cancer Registry data until December 31, 2017. Self-reported questionnaires were used to survey alcohol consumption-related factors (duration, frequency, amount, and type of alcoholic beverages). The frequency and amount of alcohol consumption were combined to explore GC risk according to 4 drinking patterns: “infrequent-light”, “frequent-light”, “infrequent-heavy”, and “frequent-heavy”. We used Cox proportional hazard models to estimate the adjusted hazard ratios (HRs) and 95% confidence intervals (CIs), and investigate the relationship between alcohol intake and GC incidence. Results: A total of 128,218 participants were included in the analysis. During an average follow-up period of 8.6 years, 462 men and 385 women were diagnosed with GC. In men, current drinkers showed a 31% greater risk of GC than non-drinkers (HR 1.31, 95% CI 1.03–1.66), whereas no significant association was observed in women. In men, GC risk was associated with a higher frequency (P trend 0.02) and dose of ethanol intake in grams (P trend 0.03). In men, the “frequent-light” (≥5 times/week and <40 g ethanol/day) drinking pattern was associated with a 46% greater risk of GC (HR 1.46, 95% CI 1.02–2.07) than the “infrequent-light” pattern (<5 times/week and <40 g ethanol/day). Conclusions: This study suggests that frequent intake of alcohol, even in low quantities per session, increases GC risk. Further research is warranted to evaluate the relationship between alcohol and GC in detail.

10 January 2025 in Epidemiologic Reviews
Verified
Journal Article
Closed access
JFJialei Fu
Jialei Fu
WSWoo-Kyoung Shin
Woo-Kyoung Shin
DHDan Huang
Dan Huang
KTKatherine De la Torre
Katherine De la Torre
Daehee KangDaehee Kang
Daehee Kang
SSSangah Shin
Sangah Shin
Gastric cancer is the fifth most common cancer and a leading cause of death worldwide. Despite a substantial body of research exploring individual food groups or dietary patterns in isolation, few studies have assessed the overall strength of the association between multiple dietary factors and gastric cancer risk. The aim for this meta-analysis was to identify the associations between dietary factors and gastric cancer risk in the Asian population. The PubMed, Web of Science, Embase, and Scopus databases were systematically searched up to December 31, 2022. Hazard ratios (HRs) with their 95% CIs were used to calculate pooled risk estimates, and Cochran’s Q and I2 statistics were used to assess heterogeneity. Funnel plot and Egger’s tests were used to estimate publication bias. Through stepwise screening, 30 cohort studies were deemed eligible for inclusion in this review. Results indicated a high total fruit consumption may reduce gastric cancer risk by 11% (HR = 0.89; 95% CI, 0.83-0.96), whereas high salt consumption potentially increases the risk by 97% (HR = 1.97; 95% CI, 1.34-2.90) in the Asian population. However, no associations of the other 21 food groups and 2 dietary patterns (healthy and unhealthy dietary patterns) with gastric cancer risk were found. Overall, this review demonstrates that consumption of high amounts of fruit and low amounts of salt may effectively prevent gastric cancer incidence in the Asian population. More cohort studies based on the Asian population are required to confirm the association of fish, meat, coffee consumption, and dietary pattern with gastric cancer risk.

30 March 2020 in Cancers
Verified
Journal Article
Open access
PDF file
NSNan Song
Nan Song
DHDan Huang
Dan Huang
DJDoeun Jang
Doeun Jang
MKMin Jung Kim
Min Jung Kim
SJSeung-Yong Jeong
Seung-Yong Jeong
JPJi Won Park
Ji Won Park
The optimal body mass index (BMI) range for predicting survival in Asian colorectal cancer patients is unknown. We established the most appropriate cut-off point of BMI to predict better survival in Asian colorectal cancer patients using a two-stage approach. Two cohorts of colorectal cancer patients were included in this study: 5815 hospital-based development cohort and 54,043 nationwide validation cohort. To determine the optimal BMI cut-off point at diagnosis, the method of Contal and O’Quigley was used. We evaluated the association between BMI and overall survival (OS) using the Cox proportional hazard model. During a median follow-up of 5.7 and 5.1 years for the development and the validation cohort, 1180 (20.3%) and 10,244 (19.0%) deaths occurred, respectively. The optimal cut-off of BMI identified as 20.2 kg/m2 (plog-rank < 8.0 × 10−16) for differentiating between poorer and better OS in the development cohort. When compared to the patients with a BMI < 20.2 kg/m2, the patients with a BMI ≥ 20.2 kg/m2 had a significantly better OS (HR = 0.62, 95% CI = 0.54–0.72, p = 1.1 × 10−10). The association was validated in the nationwide cohort, showing better OS in patients with a BMI ≥ 20.2 kg/m2 (HR = 0.64, 95% CI = 0.60–0.67, p < 0.01). We suggest the use of a BMI value of 20.2 kg/m2 to predict survival in Asian colorectal cancer patients.

2 October 2023 in Frontiers in Public Health
Verified
Journal Article
Open access
CYChunyan Yang
Chunyan Yang
MSMingsheng Sun
Mingsheng Sun
GXGuixing Xu
Guixing Xu
QLQin Luo
Qin Luo
LHLiuyang Huang
Liuyang Huang
FLFan-rong Liang
Fan-rong Liang
Background: The acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a common respiratory disease among older adults, which imposes a significant burden on individuals and society and poses a major challenge to the global public health system due to its high morbidity and mortality. Acupuncture is effective for AECOPD, but its efficacy has been questioned due to the limited methodological quality. Thus, we aim to investigate the efficacy of acupuncture as adjunctive therapy for AECOPD and determine whether the efficacy of acupuncture differs with the type of acupoint combinations.Methods and analysis: This study proposes a prospective, multicenter randomized controlled trial that will comprise four groups, including two acupuncture treatment groups, one sham acupuncture group, and one basic treatment group. The acupuncture treatment groups will be distinguished by their focus on different patterns of acupoint combination, namely the Xi-cleft and He-sea acupoint combination and the Eight Confluence points acupoint combination, which may vary in clinical efficacy based on traditional acupuncture theories. The study aims to randomize 556 patients in a 1:1:1:1 ratio across the four groups. Each patient in acupuncture group or sham acupuncture group will receive routine drug therapy and 7 sessions of acupuncture treatment over 1 week. Participants in the basic treatment group will only receive routine drug therapy. The trial will be conducted in seven hospitals located in China. The primary outcomes in this trial will include differences in the Breathlessness, Cough, and Sputum Scale (BCSS) before randomization, 7 days after randomization, 5 and 9 weeks after randomization.Ethics and dissemination: Ethical approval was obtained from the Sichuan Regional Ethics Review of Committee on Traditional Chinese Medicine (Approval ID: 2022KL-068). The results of this study will be distributed through peer-reviewed journals.Clinical Trial Registration: ClinicalTrials.gov, identifier ChiCTR2200064484.